Ligaza γ-glutamylocysteiny – od molekularnych mechanizmów regulacji aktywności enzymatycznej do implikacji terapeutycznych
By:
References
- Franklin C.C., Backos D.S., Mohar I., White C.C., Forman H.J., Kavanagh T.J.: Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase. Mol. Aspects Med., 2009; 30: 86-98
- Bilska A., Kryczyk A., Włodek L.: The different aspects of the biological role of glutathione. Postępy Hig. Med. Dośw., 2007; 61: 438-453
- Ferguson G., Bridge W.: Glutamate cysteine ligase and the age-related decline in cellular glutathione: The therapeutic potential of γ-glutamylcysteine. Arch. Biochem. Biophys., 2016; 593: 12-23
- Lu S.C.: Glutathione synthesis. Biochim. Biophys. Acta, 2013; 1830: 3143-3153
- Li S., Li X., Rozanski G.J.: Regulation of glutathione in cardiac myocytes. J. Mol. Cell. Cardiol., 2003; 35: 1145-1152
- Pompella A., Corti A., Paolicchi A., Giommarelli C., Zunino F.: γ-glutamyltransferase, redox regulation and cancer drug resistance. Curr. Opin. Pharmacol., 2007; 7: 360-366
- Meister A.: On the discovery of glutathione. Trends. Biochem. Sci., 1988; 13: 185-188
- Zarka M.H., Bridge W.J.: Oral administration of γ-glutamylcysteine increases intracellular glutathione levels above homeostasis in a randomised human trial pilot study. Redox Biol., 2017; 11: 631-636
- Franco R., Schoneveld O.J., Pappa A., Panayiotidis M.I.: The central role of glutathione in the pathophysiology of human diseases. Arch. Physiol. Biochem., 2007; 113: 234-258
- Forman H.J., Zhang H., Rinna A.: Glutathione: Overview of its protective roles, measurement, and biosynthesis. Mol. Aspects Med., 2009; 30: 1-12
- Yang Y., Chen Y., Johansson E., Schneider S.N., Shertzer H.G., Nebert D.W., Dalton T.P.: Interaction between the catalytic and modifier subunits of glutamate-cysteine ligase. Biochem. Pharmacol., 2007; 74: 372-381
- Shi Z.Z., Osei-Frimpong J., Kala G., Kala S.V., Barrios R.J., Habib G.M., Lukin D.J., Danney C.M., Matzuk M.M., Lieberman M.W.: Glutathione synthesis is essential for mouse development but not for cell growth in culture. Proc. Natl. Acad. Sci. USA, 2000; 97: 5101-5106
- Yang Y., Dieter M.Z., Chen Y., Shertzer H.G., Nebert D.W., Dalton T.P.: Initial characterization of the glutamate-cysteine ligase modifier subunit Gclm(-/-) knockout mouse. Novel model system for a severely compromised oxidative stress response. J. Biol. Chem., 2002; 277: 49446-49452
- Mulcahy R.T., Bailey H.H., Gipp J.J.: Up-regulation of γ-glutamylcysteine synthetase activity in melphalan-resistant human multiple myeloma cells expressing increased glutathione levels. Cancer Chemother. Pharmacol., 1994; 34: 67-71
- Iles K.E., Liu R.M.: Mechanisms of glutamate cysteine ligase (GCL) induction by 4-hydroxynonenal. Free Radic. Biol. Med., 2005; 38: 547-556
- Krejsa C.M., Franklin C.C., White C.C., Ledbetter J.A., Schieven G.L., Kavanagh T.J.: Rapid activation of glutamate cysteine ligase following oxidative stress. J. Biol. Chem., 2010; 285: 16116-16124
- Liu R.M., Gao L., Choi J., Forman H.J.: Gamma-glutamylcysteine synthetase: mRNA stabilization and independent subunit transcription by 4-hydroxy-2-nonenal. Am. J. Physiol., 1998; 275: L861-L869
- Liu R.M., Hu H., Robison T.W., Forman H.J.: Differential enhancement of γ-glutamyl transpeptidase and γ-glutamylcysteine synthetase by tert-butylhydroquinone in rat lung epithelial L2 cells. Am. J. Respir. Cell Mol. Biol., 1996; 14: 186-191
- Zhang H., Court N., Forman H.J.: Submicromolar concentrations of 4-hydroxynonenal induce glutamate cysteine ligase expression in HBE1 cells. Redox Rep., 2007; 12: 101-106
- Benassi B., Fanciulli M., Fiorentino F., Porrello A., Chiorino G., Loda M., Zupi G., Biroccio A.: c-Myc phosphorylation is required for cellular response to oxidative stress. Mol. Cell., 2006; 21: 509519
- Cai J., Huang Z.Z., Lu S.C.: Differential regulation of γ-glutamylcysteine synthetase heavy and light subunit gene expression. Biochem. J., 1997; 326: 167-172
- Lu S.C., Kuhlenkamp J., Garcia-Ruiz C., Kaplowitz N.: Hormone-mediated down-regulation of hepatic glutathione synthesis in the rat. J. Clin. Invest., 1991; 88: 260-269
- Kim S.K., Woodcroft K.J., Khodadadeh S.S., Novak R.F.: Insulin signaling regulates γ-glutamylcysteine ligase catalytic subunit expression in primary cultured rat hepatocytes. J. Pharmacol. Exp. Ther., 2004; 311: 99-108
- Eaton D.L., Hamel D.M.: Increase in γ-glutamylcysteine synthetase activity as a mechanism for butylated hydroxyanisole-mediated elevation of hepatic glutathione. Toxicol. Appl. Pharmacol., 1994; 126: 145-149
- Urata Y., Honma S., Goto S., Todoroki S., Iida T., Cho S., Honma K., Kondo T.: Melatonin induces γ-glutamylcysteine synthetase mediated by activator protein-1 in human vascular endothelial cells. Free Radic. Biol. Med., 1999; 27: 838-847
- Langston J.W., Li W., Harrison L., Aw T.Y.: Activation of promoter activity of the catalytic subunit of γ-glutamylcysteine ligase (GCL) in brain endothelial cells by insulin requires antioxidant response element 4 and altered glycemic status: Implication for GCL expression and GSH synthesis. Free Radic. Biol. Med., 2011; 51: 1749-1757
- Kensler T.W., Wakabayashi N., Biswal S.: Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol., 2007; 47: 89-116
- Chan K., Han X.D., Kan Y.W.: An important function of Nrf2 in combating oxidative stress: Detoxification of acetaminophen. Proc. Natl. Acad. Sci. USA, 2001; 98: 4611-4616
- Wild A.C., Moinova H.R., Mulcahy R.T.: Regulation of γ-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. J. Biol. Chem., 1999; 274: 33627-33636
- Chen Y., Shertzer H.G., Schneider S.N., Nebert D.W., Dalton T.P.: Glutamate cysteine ligase catalysis: Dependence on ATP and modifier subunit for regulation of tissue glutathione levels. J. Biol. Chem., 2005; 280: 33766-33774
- Fraser J.A., Kansagra P., Kotecki C., Saunders R.D., McLellan L.I.: The modifier subunit of Drosophila glutamate-cysteine ligase regulates catalytic activity by covalent and noncovalent interactions and influences glutathione homeostasis in vivo. J. Biol. Chem., 2003; 278: 46369-46377
- Huang C.S., Chang L.S., Anderson M.E., Meister A.: Catalytic and regulatory properties of the heavy subunit of rat kidney gamma-glutamylcysteine synthetase. J. Biol. Chem., 1993; 268: 19675-19680
- Levonen A.L., Landar A., Ramachandran A., Ceaser E.K., Dickinson D.A., Zanoni G., Morrow J.D., Darley-Usmar V.M.: Cellular mechanisms of redox cell signalling: Role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. Biochem. J., 2004; 378: 373-382
- Tu Z., Anders M.W.: Identification of an important cysteine residue in human glutamate-cysteine ligase catalytic subunit by site-directed mutagenesis. Biochem. J., 1998; 336: 675-680
- Backos D.S., Fritz K.S., Roede J.R., Petersen D.R., Franklin C.C.: Posttranslational modification and regulation of glutamatecysteine ligase by the α,β-unsaturated aldehyde 4-hydroxy-2-non-enal. Free Radic. Biol. Med., 2011; 50: 14-26
- Hayashi H., Iimuro M., Matsumoto Y., Kaneko M.: Effects of gamma-glutamylcysteine ethyl ester on heart mitochondrial creatine kinase activity: Involvement of sulfhydryl groups. Eur. J. Pharmacol., 1998; 349: 133-136
- Toroser D., Yarian C.S., Orr W.C., Sohal R.S.: Mechanisms of γ-glutamylcysteine ligase regulation. Biochim. Biophys. Acta, 2006; 1760: 233-244
- Sekhar K.R., Freeman M.L.: Autophosphorylation inhibits the activity of γ-glutamylcysteine synthetase. J. Enzyme Inhib., 1999; 14: 323-330
- Zhu M., Bowden G.T.: Molecular mechanism(s) for UV-B irradiation-induced glutathione depletion in cultured human keratinocytes. Photochem. Photobiol., 2004; 80: 191-196
- Soltaninassab S.R., Sekhar K.R., Meredith M.J., Freeman M.L.: Multi-faceted regulation of γ-glutamylcysteine synthetase. J. Cell Physiol., 2000; 182: 163-170
- Abdelmegeed M.A., Jang S., Banerjee A., Hardwick J.P., Song B.J.: Robust protein nitration contributes to acetaminophen-induced mitochondrial dysfunction and acute liver injury. Free Radic. Biol. Med., 2013; 60: 211-222
- Braidy N., Zarka M., Jugder B.E., Welch J., Jayasena T., Chan D.K.Y., Sachdev P., Bridge W.: The precursor to glutathione (GSH), γ-Glutamylcysteine (GGC), can ameliorate oxidative damage and neuroinflammation induced by Aβ40 oligomers in human astrocytes. Front Aging Neurosci., 2019; 11: 177
- Ristoff E., Larsson A.: Inborn errors in the metabolism of glutathione. Orphanet J. Rare Dis., 2007; 2: 16
- Hamilton D., Wu J.H., Alaoui-Jamali M., Batist G.: A novel missense mutation in the γ-glutamylcysteine synthetase catalytic subunit gene causes both decreased enzymatic activity and glutathione production. Blood, 2003; 102: 725-730
- Mañú Pereira M., Gelbart T., Ristoff E., Crain K.C., Bergua J.M., López Lafuente A., Kalko S.G., García Mateos E., Beutler E., Vives Corrons J.L.: Chronic non-spherocytic hemolytic anemia associated with severe neurological disease due to γ-glutamylcysteine synthetase deficiency in a patient of Moroccan origin. Haematologica, 2007; 92: e102-105
- Gutowicz M.: The influence of reactive oxygen species on the central nervous system. Postępy Hig. Med. Dośw., 2011; 65: 104113
- Johnson W.M., Wilson-Delfosse A.L., Mieyal J.J.: Dysregulation of glutathione homeostasis in neurodegenerative diseases. Nutrients, 2012; 4: 1399-1440
- Pearce R.K., Owen A., Daniel S., Jenner P., Marsden C.D.: Alterations in the distribution of glutathione in the substantia nigra in Parkinson’s disease. J. Neural. Transm., 1997; 104: 661-677
- Garrido M., Tereshchenko Y., Zhevtsova Z., Taschenberger G., Bähr M., Kügler S.: Glutathione depletion and overproduction both initiate degeneration of nigral dopaminergic neurons. Acta Neuropathol., 2011; 121: 475-485
- Sabens E.A., Distler A.M., Mieyal J.J.: Levodopa deactivates enzymes that regulate thiol-disulfide homeostasis and promotes neuronal cell death: Implications for therapy of Parkinson’s disease. Biochemistry, 2010; 49: 2715-2724
- Feng W., Rosca M., Fan Y., Hu Y., Feng P., Lee H.G., Monnier V.M., Fan X.: Gclc deficiency in mouse CNS causes mitochondrial damage and neurodegeneration. Hum. Mol. Genet., 2017; 26: 1376-1390
- Fernandez-Fernandez S., Bobo-Jimenez V., Requejo-Aguilar R., Gonzalez-Fernandez S., Resch M., Carabias-Carrasco M., Ros J., Almeida A., Bolaños J.P.: Hippocampal neurons require a large pool of glutathione to sustain dendrite integrity and cognitive function. Redox Biol., 2018; 19: 52-61
- Liu R.M.: Down-regulation of γ-glutamylcysteine synthetase regulatory subunit gene expression in rat brain tissue during aging. J. Neurosci. Res., 2002; 68: 344-351
- Pessayre D., Fromenty B., Berson A., Robin M.A., Lettéron P., Moreau R., Mansouri A.: Central role of mitochondria in drug-induced liver injury. Drug Metab. Rev., 2012; 44: 34-87
- Chen Y., Dong H., Thompson D.C., Shertzer H.G., Nebert D.W., Vasiliou V.: Glutathione defense mechanism in liver injury: Insights from animal models. Food Chem. Toxicol., 2013; 60: 38-44
- Chen Y., Yang Y., Miller M.L., Shen D., Shertzer H.G., Stringer K.F., Wang B., Schneider S.N., Nebert D.W., Dalton T.P.: Hepatocyte-specific Gclc deletion leads to rapid onset of steatosis with mitochondrial injury and liver failure. Hepatology, 2007; 45: 11181128
- McConnachie L.A., Mohar I., Hudson F.N., Ware C.B., Ladiges W.C., Fernandez C., Chatterton-Kirchmeier S., White C.C., Pierce R.H., Kavanagh T.J.: Glutamate cysteine ligase modifier subunit deficiency and gender as determinants of acetaminophen-induced hepatotoxicity in mice. Toxicol. Sci., 2007; 99: 628-636
- Jaeschke H., McGill M.R., Williams C.D., Ramachandran A.: Current issues with acetaminophen hepatotoxicity – a clinically relevant model to test the efficacy of natural products. Life Sci., 2011; 88: 737-745
- Pervaiz S., Clement M.V.: Tumor intracellular redox status and drug resistance-serendipity or a causal relationship? Curr. Pharm. Des., 2004; 10: 1969-1977
- Ballatori N., Krance S.M., Notenboom S., Shi S., Tieu K., Hammond C.L.: Glutathione dysregulation and the etiology and progression of human diseases. Biol. Chem., 2009; 390: 191-214
- Estrela J.M., Ortega A., Obrador E.: Glutathione in cancer biology and therapy. Crit. Rev. Clin. Lab. Sci., 2006; 43: 143-181
- Traverso N., Ricciarelli R., Nitti M., Marengo B., Furfaro A.L., Pronzato M.A., Marinari U.M., Domenicotti C.: Role of glutathione in cancer progression and chemoresistance. Oxid. Med. Cell. Longev., 2013; 2013: 972913
- Briehl M.M., Tome M.E., Wilkinson S.T., Jaramillo M.C., Lee K.: Mitochondria and redox homoeostasis as chemotherapeutic targets. Biochem. Soc. Trans., 2014; 42: 939-944
- Jang J.H., Surh Y.J.: Bcl-2 attenuation of oxidative cell death is associated with up-regulation of γ-glutamylcysteine ligase via constitutive NF-κB activation. J. Biol. Chem., 2004; 279: 38779-38786
- Järvinen K., Soini Y., Kahlos K., Kinnula V.L.: Overexpression of γ-glutamylcysteine synthetase in human malignant mesothelioma. Hum. Pathol., 2002; 33: 748-755
- Kim A.D., Zhang R., Han X., Kang K.A., Piao M.J., Maeng Y.H., Chang W.Y., Hyun J.W.: Involvement of glutathione and glutathione metabolizing enzymes in human colorectal cancer cell lines and tissues. Mol. Med. Rep., 2015; 12: 4314-4319
- Nguyen A., Loo J.M., Mital R., Weinberg E.M., Man F.Y., Zeng Z., Paty P.B., Saltz L., Janjigian Y.Y., de Stanchina E., Tavazoie S.F.: PKLR promotes colorectal cancer liver colonization through induction of glutathione synthesis. J. Clin. Invest., 2016; 126: 681-694
- Sun J., Zhou C., Ma Q., Chen W., Atyah M., Yin Y., Fu P., Liu S., Hu B., Ren N., Zhou H.: High GCLC level in tumor tissues is associated with poor prognosis of hepatocellular carcinoma after curative resection. J. Cancer., 2019; 10: 3333-3343
- Fiorillo M., Sotgia F., Sisci D., Cappello A.R., Lisanti M.P.: Mitochondrial “power” drives tamoxifen resistance: NQO1 and GCLC are new therapeutic targets in breast cancer. Oncotarget, 2017; 8: 20309-20327
- Hiyama N., Ando T., Maemura K., Sakatani T., Amano Y., Watanabe K., Kage H., Yatomi Y., Nagase T., Nakajima J., Takai D.: Glutamate-cysteine ligase catalytic subunit is associated with cisplatin resistance in lung adenocarcinoma. Jpn. J. Clin. Oncol., 2018; 48: 303-307
- Lin L.C., Chen C.F., Ho C.T., Liu J.J., Liu T.Z., Chern C.L.: γ-Glutamylcysteine synthetase (γ-GCS) as a target for overcoming chemo- and radio-resistance of human hepatocellular carcinoma cells. Life Sci., 2018; 198: 25-31
- Liu C.W., Hua K.T., Li K.C., Kao H.F., Hong R.L., Ko J.Y., Hsiao M., Kuo M.L., Tan C.T.: Histone methyltransferase G9a drives chemotherapy resistance by regulating the glutamate-cysteine ligase catalytic subunit in head and neck squamous cell carcinoma. Mol. Cancer Ther., 2017; 16: 1421-1434
- Nowakowska A., Tarasiuk J.: Invasion and metastasis of tumour cells resistant to chemotherapy. Postępy Hig. Med. Dośw., 2017; 71: 380-397
- Almusafri F., Elamin H.E., Khalaf T.E., Ali A., Ben-Omran T., El-Hattab A.W.: Clinical and molecular characterization of 6 children with glutamate-cysteine ligase deficiency causing hemolytic anemia. Blood Cells Mol. Dis., 2017; 65: 73-77
- Chen Y., Johansson E., Yang Y., Miller M.L., Shen D., Orlicky D.J., Shertzer H.G., Vasiliou V., Nebert D.W., Dalton T.P.: Oral N-acetylcysteine rescues lethality of hepatocyte-specific Gclcknockout mice, providing a model for hepatic cirrhosis. J. Hepatol., 2010; 53: 1085-1094
- Rushworth G.F., Megson I.L.: Existing and potential therapeutic uses for N-acetylcysteine: The need for conversion to intracellular glutathione for antioxidant benefits. Pharmacol. Ther., 2014; 141: 150-159
- Witschi A., Reddy S., Stofer B., Lauterburg B.H.: The systemic availability of oral glutathione. Eur. J. Clin. Pharmacol., 1992; 43: 667-669
- Levy E.J., Anderson M.E., Meister A.: Transport of glutathione diethyl ester into human cells. Proc. Natl. Acad. Sci. USA, 1993; 90: 9171-9175
- Du K., Ramachandran A., Jaeschke H.: Oxidative stress during acetaminophen hepatotoxicity: Sources, pathophysiological role and therapeutic potential. Redox Biol. 2016; 10: 148-156
- Quintana-Cabrera R., Fernandez-Fernandez S., Bobo-Jimenez V., Escobar J., Sastre J., Almeida A., Bolaños J.P.: γ-Glutamylcysteine detoxifies reactive oxygen species by acting as glutathione peroxidase-1 cofactor. Nat. Commun., 2012; 3: 718
- Chandler S.D., Zarka M.H., Vinaya Babu S.N., Suhas Y.S., Raghunatha Reddy K.R., Bridge W.J.: Safety assessment of gammaglutamylcysteine sodium salt. Regul. Toxicol. Pharmacol., 2012; 64: 17-25
- Kobayashi H., Kurokawa T., Kitahara S., Nonami T., Harada A., Nakao A., Sugiyama S., Ozawa T., Takagi H.: The effects of gamma-glutamylcysteine ethyl ester, a prodrug of glutathione, on ischemia-reperfusion-induced liver injury in rats. Transplantation, 1992; 54: 414-418
- Le T.M., Jiang H., Cunningham G.R., Magarik J.A., Barge W.S., Cato M.C., Farina M., Rocha J.B., Milatovic D., Lee E. i wsp.: γ-Glutamylcysteine ameliorates oxidative injury in neurons and astrocytes in vitro and increases brain glutathione in vivo. Neurotoxicology, 2011; 32: 518-525
- Yang Y., Li L., Hang Q., Fang Y., Dong X., Cao P., Yin Z., Luo L.: γ-glutamylcysteine exhibits anti-inflammatory effects by increasing cellular glutathione level. Redox Biol., 2019; 20: 157-166
- Salama S.A., Arab H.H., Hassan M.H., Al Robaian M.M., Maghrabi I.A.: Cadmium-induced hepatocellular injury: Modulatory effects of γ-glutamyl cysteine on the biomarkers of inflammation, DNA damage, and apoptotic cell death. J. Trace. Elem. Med. Biol., 2019; 52: 74-82
- Salama S.A., Arab H.H., Maghrabi I.A., Hassan M.H., AlSaeed M.S.: Gamma-glutamyl cysteine attenuates tissue damage and enhances tissue regeneration in a rat model of lead-induced nephrotoxicity. Biol. Trace Elem. Res., 2016; 173: 96-107
DOI: https://doi.org/10.2478/ahem-2021-0013 | Journal eISSN: 1732-2693
Language: English
Page range: 823 - 836
Submitted on: Sep 17, 2020
Accepted on: Apr 14, 2021
Published on: Dec 7, 2021
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Related subjects:
© 2021 Bożena Gabryel, Klaudia Bontor, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.